News

Researchers have created a plug-and-play multi-organ chip the size of a microscope slide that can be customized to the patient.

Scientists have discovered a combination therapy for treating triple-negative breast cancer that results in durable tumor regression in an animal model of the disease.

Researchers have found a way to identify the immune cells involved in autoimmune diseases and have discovered four new target molecules of potential significance for future personalized treatment of multiple sclerosis.

A new class of material has been designed that can withstand the acidic conditions of the stomach to deliver medicines to the small intestine, helping to expand the number of medications that can be delivered orally.

A team of scientists has discovered a promising treatment strategy targeting the protein tau that could be useful for Dravet syndrome, epilepsy, autism and Alzheimer's disease.

A new study shows that it is possible to use the genetic sequences of a person’s antibodies to predict what pathogens those antibodies will target.

Researchers set out to find new ways to artificially induce mRNA to respond in ways that could eventually lead to therapeutic outcomes, expanding on the success of the mRNA-based COVID-19 vaccines.

Researchers have developed an artificial intelligence approach that only proposes new drug molecules that can actually be synthesized in a laboratory.

A team has reduced chronic inflammation in a mouse model of multiple sclerosis thanks to the administration of a type of lipid that mediates inflammation.

A study that examined gene mutations in people with a rare condition that stops them sweating or feeling pain could point the way towards identifying new drug targets for people suffering from chronic pain.